Franklin Resources’s Celldex Therapeutics CLDX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-23,003
| Closed | -$780K | – | 2677 |
|
|
2023
Q2 | $780K | Buy |
+23,003
| New | +$780K | ﹤0.01% | 1736 |
|
|
2022
Q1 | – | Sell |
-5,301
| Closed | -$205K | – | 2451 |
|
|
2021
Q4 | $205K | Buy |
5,301
+129
| +2% | +$4.99K | ﹤0.01% | 2231 |
|
|
2021
Q3 | $279K | Buy |
+5,172
| New | +$279K | ﹤0.01% | 2105 |
|
|
2017
Q3 | – | Sell |
-829
| Closed | -$31K | – | 1484 |
|
|
2017
Q2 | $31K | Sell |
829
-350,407
| -100% | -$13.1M | ﹤0.01% | 1494 |
|
|
2017
Q1 | $19M | Sell |
351,236
-64,315
| -15% | -$3.48M | 0.01% | 799 |
|
|
2016
Q4 | $22.1M | Sell |
415,551
-4,662
| -1% | -$248K | 0.01% | 769 |
|
|
2016
Q3 | $25.5M | Sell |
420,213
-320
| -0.1% | -$19.4K | 0.01% | 737 |
|
|
2016
Q2 | $27.7M | Sell |
420,533
-183,893
| -30% | -$12.1M | 0.01% | 705 |
|
|
2016
Q1 | $34.3M | Sell |
604,426
-49,233
| -8% | -$2.79M | 0.02% | 644 |
|
|
2015
Q4 | $154M | Buy |
653,659
+48,429
| +8% | +$11.4M | 0.08% | 261 |
|
|
2015
Q3 | $95.7M | Buy |
605,230
+29,291
| +5% | +$4.63M | 0.05% | 360 |
|
|
2015
Q2 | $218M | Sell |
575,939
-2,271
| -0.4% | -$859K | 0.1% | 228 |
|
|
2015
Q1 | $242M | Sell |
578,210
-59,795
| -9% | -$25M | 0.11% | 208 |
|
|
2014
Q4 | $175M | Sell |
638,005
-43,825
| -6% | -$12M | 0.08% | 251 |
|
|
2014
Q3 | $133M | Sell |
681,830
-24,950
| -4% | -$4.85M | 0.06% | 302 |
|
|
2014
Q2 | $173M | Buy |
706,780
+47,896
| +7% | +$11.7M | 0.08% | 267 |
|
|
2014
Q1 | $175M | Buy |
658,884
+130,216
| +25% | +$34.5M | 0.08% | 255 |
|
|
2013
Q4 | $192M | Sell |
528,668
-4,374
| -0.8% | -$1.59M | 0.09% | 232 |
|
|
2013
Q3 | $283M | Sell |
533,042
-36,894
| -6% | -$19.6M | 0.15% | 166 |
|
|
2013
Q2 | $133M | Buy |
+569,936
| New | +$133M | 0.08% | 255 |
|